Empowering Biotech Innovation
Accelerating access to life-changing therapies.
Biotechnology provides a world filled with boundless opportunities and potential. Building a biotech is not just a venture—it’s a journey into the unknown. A high risk, stressful and capital consuming endeavor. Arguably one of the toughest things to decide to do… BUT every moment is an opportunity to build something transformative for patients and make your mark on the world….
Driving Innovation in Biotechnology for Global Health
Why I Started This Blog
I’ve been fortunate to start and build several biotech companies—mostly from the ground up, often from places that didn’t have all the pieces in place. In fact, to get my first real venture going, I had to leave Australia and set up in the U.S., where the infrastructure, mindset, and capital aligned more easily for biotech innovation.
Now, after years navigating both the science and the business of therapeutics—across continents, funding cycles, and technologies—I’m trying to put something back into the public domain. This blog is a way to do that.
These posts reflect lessons learned, observations from the field, and thoughts on where things might go next. They’re based on my personal experiences but don’t represent the views of any companies I’m involved with. My hope is that they help founders, students, policymakers—or anyone curious about the inner workings of biotech startups—find something useful, or at least thought-provoking.
This is not advice. It’s just one perspective. But I believe there’s value in sharing the journey as honestly as possible.
Key Metrics Reflecting Impact in Biotechnology
The road to approved therapies is long,
Latest Blog Posts
-
Rethinking How We Build Biotech Companies
Borrowing From Tech To Build Product-Platform Biotech’s Introduction In the world of technology, there’s a well-known principle from Intel’s Andy Grove: every product should be ten times better than the one before it (a concept well outlined in his book High Output Management). That kind of exponential leap has powered decades of innovation in Silicon…
-
Biotech Sector Correction: Moving Beyond the Bubble
The recent narrative framing biotech’s current struggles as a dawn after darkness ignores a critical reality: the sector is not just emerging from a difficult period but is in fact correcting from an unsustainable bubble. The exuberance that characterized the biotech industry during the pandemic years created an inflated market that was bound to contract….
Join the Biotech Movement
Be Part of the Biotech Innovation Revolution